Please login to the form below

Not currently logged in

Anti-trust inquiry: Merck, Schering-Plough

The US FTC has requested that Merck & Co and Schering-Plough must provide additional information regarding their $41.1bn merger

The US Federal Trade Commission (FTC) has requested that Merck & Co and Schering-Plough must provide additional information regarding their $41.1bn merger.

The query is mostly about the company's animal-health units and was reportedly "anticipated" by the New Jersey-based drugmakers which still plan to close the deal this year.

On June 3, Merck said that it planned to sell one of the companies' animal health units to help fund the acquisition and reduce overlap. If a sale doesn't settle FTC concerns about competition in the animal drug industry, Merck or Schering-Plough may have to put more products on the market.

Analyst David Moskowitz of Caris & Co said: "There's going to be many more products for sale. It could affect pricing in the sense that Merck really wants to get those approvals." He added that antitrust concerns are unlikely to prevent the merger. "Merck absolutely needs to get this done to produce growth over the next couple of years." 

23rd June 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...